-+ 0.00%
-+ 0.00%
-+ 0.00%

Liminatus Pharma Unveils Strategic Expansion Into Crypto Sector With Planned $500M Investment In BNB Coin Via New Subsidiary "American BNB Strategy"

Benzinga·07/28/2025 11:35:21
Listen to the news

Liminatus Pharma, Inc. (NASDAQ:LIMN), a preclinical-stage biopharmaceutical company dedicated to the development of targeted cancer immunotherapies, today announced plans for a strategic expansion into the cryptocurrency and blockchain sector.

The company intends to establish a dedicated subsidiary, named "American BNB Strategy," to lead its digital asset investment and management initiatives. Through this planned vehicle, Liminatus aims to raise and deploy up to $500 million in phases, targeting strategic, long-term investments in BNB coin (Build and Build) the native token of the Binance ecosystem, the world's largest digital asset exchange.